GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Net Income From Continuing Operations

MDBIF (TrivarX) Net Income From Continuing Operations : $-0.16 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. TrivarX's net income from continuing operations for the six months ended in Dec. 2024 was $-0.06 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.16 Mil.


TrivarX Net Income From Continuing Operations Historical Data

The historical data trend for TrivarX's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Net Income From Continuing Operations Chart

TrivarX Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.67 -1.14 -8.94 -2.09 -0.82

TrivarX Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.28 -1.81 -0.73 -0.10 -0.06

TrivarX Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TrivarX Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.

TrivarX Headlines

From GuruFocus

Medibio Granted CE Mark Approval for MEBsleep

By PRNewswire PRNewswire 01-19-2021

Medibio Announces Next Tranche of Corporate Health Contracts

By Marketwired Marketwired 05-10-2018

Departure of Managing Director & Chief Executive Officer

By Marketwired Marketwired 08-29-2018

Medibio Releases Corporate Health Product, ilumen™

By Marketwired Marketwired 10-03-2018

Peer-reviewed Neurology Publication on Medibio Science

By Marketwired Marketwired 06-27-2018

Medibio Announces Scientific Advisory Board

By Marketwired Marketwired 04-26-2018

Medibio Limited Quarterly ASX Update and Cashflows

By Marketwired Marketwired 10-30-2018

Medibio finalizes acquisition of Vital Conversations

By Marketwired Marketwired 04-12-2018